{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:36:03Z","timestamp":1794551763140,"version":"4.9.1"},"reference-count":148,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Enable Injections, Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["mAbs"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/19420862.2023.2285277","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T01:52:00Z","timestamp":1701136320000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":95,"title":["Monoclonal antibody and protein therapeutic formulations for subcutaneous delivery: high-concentration, low-volume vs. low-concentration, high-volume"],"prefix":"10.1080","volume":"15","author":[{"given":"M.","family":"Desai","sequence":"first","affiliation":[{"name":"Enable Injections, Inc","place":["Cincinnati, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kundu","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals","place":["Brooklyn Park, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hageman","sequence":"additional","affiliation":[{"name":"The University of Kansas","place":["Lawrence, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lou","sequence":"additional","affiliation":[{"name":"The University of Kansas","place":["Lawrence, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Boisvert","sequence":"additional","affiliation":[{"name":"Independent Chemistry Manufacturing & Controls (CMC) Consultant","place":["El Cerrito, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2012.51"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092325"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/abt\/tbac021"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-022-01630-6"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s287323"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/23808993.2019.1585806"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2017.06.029"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0859-z"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2017.1392424"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2020.02.036"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2020.05.009"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-018-0295-0"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.9126"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3026(20)30070-3"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0167"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-158146"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2021.11.008"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/ceor.S302682"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157957"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.573"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.2147\/ppa.S198953"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu364"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.2147\/ppa.S303279"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.2147\/ceor.S317687"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hjdsi.2016.04.004"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-136543"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2015.09.2852"},{"key":"e_1_3_3_29_1","first-page":"1579","article-title":"Subcutaneous administration of anticancer agents","volume":"34","author":"Leveque D","year":"2014","unstructured":"Leveque D. Subcutaneous administration of anticancer agents. Anticancer Res. 2014;34:1579\u201386.","journal-title":"Anticancer Res"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-01101-6"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16980"},{"key":"e_1_3_3_32_1","volume-title":"Poster presented at: 2023 PDA Universe of Pre-Filled Syringes and Injection Devices Conference: 20 Years of Innovation in Drug Delivery - What\u2019s Next?","author":"Desai M.","year":"2023","unstructured":"Desai M. Exploring U.S. payer perspectives on a large-volume subcutaneous on-body delivery system: a double-blinded preference study. Poster presented at: 2023 PDA Universe of Pre-Filled Syringes and Injection Devices Conference: 20 Years of Innovation in Drug Delivery - What\u2019s Next?; 17-18 Oct 2023; Gothenburg, Sweden."},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2016.05.029"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20079"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2021.03.017"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2014.08.001"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.08.001"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23324"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21322"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20347"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2211185"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2020.09.014"},{"key":"e_1_3_3_43_1","volume-title":"Poster presented at: European Association of Hospital Pharmacists 26th Congress","author":"Ammor W","year":"2022","unstructured":"Ammor W, Chapron P, Goubil A, Fronteau C, Peyrilles E, Cormier N. Optimization of the subcutaneous administration of daratumumab. Poster presented at: European Association of Hospital Pharmacists 26th Congress; 23\u201325 March 2022; Vienna, Austria."},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/08990220600700925"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-8-38"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.3109\/2000656x.2015.1111223"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.11.012"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00245-0"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2022.2116425"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2022.08.036"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1021\/nn204166z"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23256"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2019.10.033"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2020.1796630"},{"key":"e_1_3_3_55_1","article-title":"Osmosis","author":"Lopez M","year":"2023","unstructured":"Lopez M, Physiology HC. Osmosis. StatPearls [Internet]. 2023.","journal-title":"StatPearls [Internet]"},{"key":"e_1_3_3_56_1","first-page":"325","volume-title":"Pharmaceutical preformulation and formulation: a practical guide from candidate drug selection to commercial dosage form","author":"Broadhead J","year":"2009","unstructured":"Broadhead J, Gibson M. Parenteral dosage forms. In: Gibson M, editor. Pharmaceutical preformulation and formulation: a practical guide from candidate drug selection to commercial dosage form. 2nd ed. 2009. p. 325\u201347. Boca Raton, Florida, USA: CRC Press.","edition":"2"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.05.069"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)54607-X"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi951526c"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2019.08.009"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.862456"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2015.1029217"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2019.06.011"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-021-03047-3"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2006.pto_271.x"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.13285"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-021-03022-y"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-023-00798-2"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.3390\/antib2030452"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.01.015"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2020.08.014"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-018-0560-5"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa580"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.5414\/cp202714"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.279459"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2823"},{"key":"e_1_3_3_77_1","unstructured":"Pharmaceuticals A. BLA multi\u2010disciplinary review and evaluation BLA 761108 ultomiris (ravulizumab). Biologic license application. (18June2018)."},{"key":"e_1_3_3_78_1","unstructured":"Apellis announces U.S. Food and Drug Administration (FDA) approval of EMPAVELI\u2122 (pegcetacoplan) for adults with paroxysmal nocturnal hemoglobinuria (PNH). 14 May 2021. https:\/\/investors.apellis.com\/news-releases\/news-release-details\/apellis-announces-us-food-and-drug-administration-fda-approval."},{"key":"e_1_3_3_79_1","unstructured":"Corrected supplement approval (2022)."},{"key":"e_1_3_3_80_1","unstructured":"Apellis announces U.S. FDA approval of the EMPAVELI\u00ae injector a device to streamline self-administration. 2 Oct 2023. https:\/\/investors.apellis.com\/news-releases\/news-release-details\/apellis-announces-us-fda-approval-empavelir-injector-device."},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009337512"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-015-0288-y"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.11.015"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13109"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.120164"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2019.06.008"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2022-0097"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0276814"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.4103\/2230-973x.93004"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.10.006"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2018.1560211"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-012-1034-4"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13170"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04093.x"},{"key":"e_1_3_3_95_1","volume-title":"Annual Scientific Meeting of the American College of Allergy, Asthma, & Immunology","author":"Wasserman RL","unstructured":"Wasserman RL, Melamed I, Stein M, Engl, W, Leibl, H, McCoy, B, Gelmont, D, Schiff, RI et al. Pharmacokinetics of recombinant human hyaluronidase (rHUPH20)-facilitated subcutaneous infusion of immune globulin (human), 10% (IGHy) in patients with primary immunodeficiency disease (PI). Annual Scientific Meeting of the American College of Allergy, Asthma, & Immunology; 2011; 3-8 November 2011 Boston, MA, USA."},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2018.1551442"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2385"},{"key":"e_1_3_3_98_1","unstructured":"Argenx announces data from phase 1 study of efgartigimod (ARGX-113) subcutaneous formulation demonstrating comparable characteristics to intravenous formulation. 14 June 2018. http:\/\/www.argenx.com."},{"key":"e_1_3_3_99_1","unstructured":"U.S. Food and Drug Administration. Herceptin HYLECTA Package Insert 2019. Accessed 10 August 2023. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/761106s000lbl.pdf."},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028019877936"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-015-2922-5"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/psp.2013.63"},{"key":"e_1_3_3_103_1","unstructured":"U.S. Food and Drug Administration. RITUXAN HYCELA Package Insert 2017. Accessed 10 August 2023. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/761064s000lbl.pdf."},{"key":"e_1_3_3_104_1","unstructured":"U.S. Food and Drug Administration. PHESGO Package Insert 2020. Accessed 10 August 2023. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/761170s000lbl.pdf."},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(20)30536-2"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1771"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.826"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.5414\/cp201847"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2022.2162037"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-015-0231-6"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1093\/abt\/tbab027"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.10.040"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21327"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1002\/bit.27510"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2009.10.006"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12551-013-0109-z"},{"key":"e_1_3_3_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2017.12.016"},{"key":"e_1_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-020-00465-4"},{"key":"e_1_3_3_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2018.09.013"},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.1021\/jp070212j"},{"key":"e_1_3_3_121_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920109788488905"},{"key":"e_1_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21530"},{"key":"e_1_3_3_123_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-012-0749-x"},{"key":"e_1_3_3_124_1","doi-asserted-by":"publisher","DOI":"10.1208\/ps050210"},{"key":"e_1_3_3_125_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-003-0014-z"},{"key":"e_1_3_3_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.03.041"},{"key":"e_1_3_3_127_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23369"},{"key":"e_1_3_3_128_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22650"},{"key":"e_1_3_3_129_1","doi-asserted-by":"publisher","DOI":"10.1023\/a:1015108115452"},{"key":"e_1_3_3_130_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2019.1658493"},{"key":"e_1_3_3_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2022.09.022"},{"key":"e_1_3_3_132_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2021.1853699"},{"key":"e_1_3_3_133_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa020888"},{"key":"e_1_3_3_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(03)14541-2"},{"key":"e_1_3_3_135_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa040528"},{"key":"e_1_3_3_136_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v98.12.3241"},{"key":"e_1_3_3_137_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21765"},{"key":"e_1_3_3_138_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh1092"},{"key":"e_1_3_3_139_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22276"},{"key":"e_1_3_3_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2013.09.006"},{"key":"e_1_3_3_141_1","doi-asserted-by":"publisher","DOI":"10.1093\/ilar.46.3.241"},{"key":"e_1_3_3_142_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.406"},{"key":"e_1_3_3_143_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155220953873"},{"key":"e_1_3_3_144_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403290"},{"key":"e_1_3_3_145_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30463"},{"key":"e_1_3_3_146_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.08.027"},{"key":"e_1_3_3_147_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203523"},{"key":"e_1_3_3_148_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517740641"},{"key":"e_1_3_3_149_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1401"}],"container-title":["mAbs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/19420862.2023.2285277","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T08:15:10Z","timestamp":1753258510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/19420862.2023.2285277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":148,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/19420862.2023.2285277"],"URL":"https:\/\/doi.org\/10.1080\/19420862.2023.2285277","relation":{},"ISSN":["1942-0862","1942-0870"],"issn-type":[{"value":"1942-0862","type":"print"},{"value":"1942-0870","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=kmab20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=kmab20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-10-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2285277"}}